4.5 Article

Sex differences in the prevalence and prognostic impact of physical frailty and sarcopenia among older patients with heart failure

Journal

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
Volume 32, Issue 2, Pages 365-372

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.numecd.2021.10.012

Keywords

Heart failure; Frailty; Sarcopenia; Sex characteristics; Prognosis

Funding

  1. Novartis Pharma Research Grants
  2. Japan Heart Foundation Research Grant
  3. JSPS KAKENHI [18K15862]

Ask authors/readers for more resources

Frailty and sarcopenia are common in elderly patients with heart failure and have a negative impact on prognosis, with no clear gender differences.
Background and aims: Frailty and sarcopenia are common and confer poor prognosis in elderly patients with heart failure; however, gender differences in its prevalence or prognostic impact remain unclear. Methods and results: We included 1332 patients aged >65 years, who were hospitalized for heart failure. Frailty and sarcopenia were defined using the Fried phenotype model and Asian Working Group for Sarcopenia criteria, respectively. Gender differences in frailty and sarcopenia, and interactions between sex and prognostic impact of frailty/sarcopenia on 1-year mortality were evaluated. Overall, 53.9% men and 61.0% women and 23.7% men and 14.0% women had frailty and sarcopenia, respectively. Although sarcopenia was more prevalent in men, no gender differences existed in frailty after adjusting for age. On Kaplan-Meier analysis, frailty and sarcopenia were significantly associated with 1-year mortality in both sexes. On Cox proportional hazard analysis, frailty was associated with 1-year mortality only in men, after adjusting for confounding factors (hazard ratio [HR], 1.94; 95% confidence interval [CI], 1.19-3.16; P = 0.008 for men; HR, 1.63; 95% CI, 0.84-3.13; P = 0.147 for women); sarcopenia was an independent prognostic factor in both sexes (HR, 1.93; 95% CI, 1.13-3.31; P = 0.017 for men; HR, 3.18; 95% CI, 1.59-5.64; P = 0.001 for women). There were no interactions between sex and prognostic impact of frailty/sarcopenia (P = 0.806 for frailty; P = 0.254 for sarcopenia). Conclusions: Frailty and sarcopenia negatively affect older patients with heart failure from both sexes. Clinical trials: This study was registered at the University Hospital Information Network (UMINCTR, unique identifier: UMIN000023929) before the first patient was enrolled. 2021 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available